Written question asked by Peter Gibson (Conservative) on Wednesday, 9 February 2022, in the House of Commons. It was due for an answer on Monday, 21 February 2022. It was answered by Maria Caulfield (Conservative) on Monday, 21 February 2022 on behalf of the Department of Health and Social Care.
Macular Degeneration: Stem Cells
- Question
-
To ask the Secretary of State for Health and Social Care, whether trials are occurring to test stem cells as a treatment for macular degeneration.
- Answer
-
Stem cell treatments for macular degeneration are in an early experimental phase of development. The National Institute for Health Research Clinical Research Network has supported a recent study (2015-2019) producing stem cells to treat age-related macular degeneration and the Clinical Research Facility Network have supported 3 studies on macular degeneration and regenerative medicine and therapeutics in the past 5 years.
Secondary information
- Type
- Written question
- Reference
- 121933
- Session
- 2021-22
- Subjects
- Macular degeneration Research Stem cells
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-02-21 13:48:57 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/121933
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/121933
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/121933